Correlation between Structural Transformations in Mesenteric Lymph Nodes and the Levels MicroRNA during

A V Kabakov1, O V Kazakov2, A F Poveshchenko2,3

  • 1Research Institute of Clinical and Experimental Lymphology - Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. kabakov_av85@mail.ru.

Insights

This study explored links between breast cancer, lymph node structure, and specific microRNAs in rats. Post-treatment, microRNA-221 and microRNA-222 levels correlated with immune cell populations in mesenteric lymph nodes.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Breast cancer involves complex interactions between tumor cells and the immune system.
  • MicroRNAs (miRNAs) play critical roles in cancer development and immune regulation.
  • Mesenteric lymph nodes are key sites for immune responses to systemic conditions like cancer.

Purpose of the Study:

  • To investigate the relationship between mesenteric lymph node cytoarchitectonics and specific miRNA levels in breast cancer.
  • To analyze miRNA profiles in lymph, serum, and breast tissue following polychemotherapy.
  • To identify correlations between miRNA expression and immune cell populations within lymph nodes.

Main Methods:

  • Chemically induced breast cancer model in female Wistar rats.
  • Analysis of microRNA-21, microRNA-221/222, and microRNA-429 levels in lymph, blood serum, and breast tissue.
  • Histological examination of mesenteric lymph node cytoarchitectonics.
  • Correlation analysis between miRNA levels and immune cell counts (lymphoblasts, macrophages).

Main Results:

  • Significant correlations were observed between microRNA-221 and lymphoblasts in germinal centers.
  • MicroRNA-222 levels correlated with lymphoblasts in germinal centers and macrophages in medullary cords.
  • These findings emerged after polychemotherapy treatment.

Conclusions:

  • Specific microRNAs (miRNA-221, miRNA-222) are associated with changes in immune cell composition within mesenteric lymph nodes during breast cancer treatment.
  • These miRNAs may serve as potential biomarkers for monitoring immune responses in breast cancer.
  • Further research is warranted to elucidate the functional roles of these miRNAs in cancer-associated lymph node alterations.